Investors

Pioneers of the world’s first diagnostic and therapeutic approach for Alzheimer’s disease

We are a pre-clinical stage bio pharmaceutical company, developing a first-in-class approach for diagnosing & treating Alzheimer’s disease

Neuro-Bio corporate presentation 2025

Click here to view our latest deck

INVESTMENT OPPORTUNITY

For more information or to be involved as an investor, please email us at info@neuro-bio.com

NeuroBio logo

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from Neuro-Bio

You have Successfully Subscribed!